1Nicholson JK, Lindon JC, Holmes E. ' Metabonomics ' : understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data [ J ]. Xenobiotica, 1999, 29: 1181-1189.
6Clarke C J, Haselden JN. Metabolic profiling as a tool for understanding mechanisms of toxicity [ J ]. Toxicol Pathol, 2008, 36: 140-147.
7Sun JC, Schnackenberg LK, Holland RD, et al. Metabonomics Evaluation of Urine from Rats Given Acute and Chronic Doses of Acetaminophen Using NMR and UPLC/MS [J]. J Chromatogr B, 2008, 84: 207-277.
8Yap IK, Clayton TA, Tang H, et al. An Integrated Metabonomic Approach To Describe Temporal Metabolic Disregulation Induced in the Rat by the Model Hepatotoxin Allyl Formate[J]. J Proteome Res, 2006, 5: 2675-2684.
9Huang X, Shao L, Gong W, et al. A metabonomic characterization of CCl4-induced acute liver failure using partial least square regression based on the GC/MS metabolic profiles of plasma in mice[J]. J Chromatogr B, 2008, 870: 178-185.
10Wang Q, Jiang Y, Wu C, et al. Study of a novel indolin-2- ketone compound Z24 induced hepatotoxicity by NMR- spectroscopy-based metabonomics of rat urine, blood plasma, and liver extracts[J]. Toxicol Appl Pharm, 2006, 215: 71- 82.
8Price KE,Lunte CE,Larive CK.Development of tissue-targeted metabonomics[J].J Phamaceut Biomed,2008,46(4):737-747.
9Vikram A,thivimj B,Hamzehzarghani H,et al.Valatilemetabolite profiling to discriminate diseases of Mclntesh apple inoculated with fungal pathogens[J].Sci Fd Agri,2004,84(11):1333-1340.
10Clayton TA,Lindon JC,Cloarec O,et al.Pharmaco-metabonomic phenotyping and personalized drug treatment[J].Nature,2006,440(20):1073-1077.